MedPath

memantine hydrochloride

These highlights do not include all the information needed to use Memantine HCl safely and effectively. See full prescribing information for Memantine HCl. Memantine HCl tablets, for oral useMemantine HCl solution, for oral use Initial U.S. Approval: 2003

Approved
Approval ID

c8f5c20b-4573-44c5-89fc-4da11b2e1fe1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2017

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

memantine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71610-011
Application NumberNDA021487
Product Classification
M
Marketing Category
C73594
G
Generic Name
memantine hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 15, 2017
FDA Product Classification

INGREDIENTS (5)

MEMANTINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 1
Code: JY0WD0UA60
Classification: ACTIB
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
hypromellosesInactive
Code: 3NXW29V3WO
Classification: IACT
polyethylene glycol 400Inactive
Code: B697894SGQ
Classification: IACT
ferrosoferric oxideInactive
Code: XM0M87F357
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

memantine hydrochloride - FDA Drug Approval Details